搜索临床试验以:PK and safety
总计474169个结果
-
Apellis Pharmaceuticals, Inc.完全的
-
Amgen终止复发/难治性急性髓系白血病 (AML)美国, 大韩民国, 澳大利亚, 日本, 德国, 加拿大
-
Ology BioservicesUnited States Department of Defense主动,不招人
-
Health Institutes of TurkeyTC Erciyes University完全的
-
Calithera Biosciences, Inc终止
-
The Aurum Institute NPCJohns Hopkins University; University of California完全的
-
Biozeus Biopharmaceutical S.A.Azidus Brasil Scientific Research and Development Ltda完全的
-
Novartis PharmaceuticalsMedicines for Malaria Venture完全的
-
Otsuka Pharmaceutical Development & Commercialization...完全的
-
Swiss Tropical & Public Health InstituteDrugs for Neglected Diseases; Ifakara Health Institute完全的
-
Ascletis Pharmaceuticals Co., Ltd.主动,不招人
-
Vertex Pharmaceuticals Incorporated完全的
-
Eloxx Pharmaceuticals, Inc.完全的
-
Global Alliance for TB Drug Development完全的
-
Novartis PharmaceuticalsMedicines for Malaria Venture完全的
-
Zogenix, Inc.完全的
-
Novartis PharmaceuticalsMedicines for Malaria Venture完全的
-
UCB Biopharma SRLParexel完全的
-
Go Medical Industries Pty LtdNational Institute on Drug Abuse (NIDA); Columbia University; New York State Psychiatric Institute 和其他合作者完全的
-
Qpex Biopharma, Inc.Biomedical Advanced Research and Development Authority完全的
-
Biohaven Pharmaceuticals, Inc.Cognitive Research Corporation完全的肌萎缩侧索硬化症 | 肌萎缩侧索硬化 | 卢格里克病 | 卢伽雷氏病 | 卢伽雷氏病 | 运动神经元病、肌萎缩侧索硬化美国
-
University of YorkWellcome Trust; European and Developing Countries Clinical Trials Partnership (EDCTP); European...撤销
-
Ultragenyx Pharmaceutical IncNovartis; Mereo BioPharma撤销稳定血液透析的慢性肾脏病 5D 期
-
Inhibrx, Inc.完全的Alpha-1 抗胰蛋白酶缺乏症 | AATD美国, 新西兰, 英国